Omnicell

Omnicell Quick Ratio

The Quick Ratio (Acid Test) of Omnicell (OMCL) as of Nov 3, 2026 is 1.28. In the previous year, Quick Ratio (Acid Test) was 0.96 — a change of 33.53% (higher).

Quick Ratio

1.28

YoY

33.53%

Last updated:

Quick Ratio (Acid Test) of Omnicell is 2025 1.28 . Quick Ratio (Acid Test) of Omnicell was 2024 0.96 . It decreases by 33.53% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omnicell Stock analysis

What does Omnicell do? Omnicell Inc. is a leading company in the healthcare industry, specializing in the development and provision of innovative automation solutions for medication and other critical medical supplies. The company was founded in 1992 and is headquartered in Mountain View, California, USA. Over the years, Omnicell has grown into a global company with offices in North America, Europe, Asia, and the Middle East. Omnicell's business model is to offer products, services, and solutions that allow healthcare facilities to optimize their processes, increase patient safety, and save costs. Omnicell provides innovative automation solutions, particularly for medication management, sterilization, and inventory control. Omnicell offers various solutions to improve medication management in clinics. This includes, for example, the medication cabinet, which has an integrated computer system that allows for the quick and easy identification and retrieval of needed medications. Omnicell also offers solutions for sterilizing medical materials to ensure patient safety, as well as automated storage systems for managing medical supplies. In recent years, the company has focused heavily on developing solutions to improve patient safety. One example is Omnicell's Medical Intelligence platform, which automatically detects and notifies of medication errors and other issues, thereby enhancing patient safety. Omnicell's products are used by a wide range of healthcare facilities, from small doctor's offices to large hospitals and health centers. The company has also established relationships with major retailers to sell its products, such as CVS and Walgreens in the USA. In addition to its core products and services, Omnicell also provides training and support to customers to ensure they can make optimal use of their products. The company also has its own research and development department to continuously develop new and innovative products and solutions. Overall, Omnicell aims to transform the healthcare industry through innovative automation solutions. Through its products, services, and solutions, the company has already helped many healthcare facilities improve their processes and increase patient safety. Omnicell will continue to invest in the development of new products and technologies to optimize the healthcare industry in the long term. Omnicell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omnicell stock

Quick Ratio (Acid Test) of Omnicell is 1.28 in 2025.

Quick Ratio (Acid Test) of Omnicell changed from 0.96 to 1.28, representing a 33.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Omnicell since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Omnicell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Omnicell

All Key Metrics — Omnicell